Immunovia AB (IMMNOV.ST)

STO Healthcare Medical - Diagnostics & Research

Immunovia AB operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Lund, SN, SE. The stock last traded at $0.14, up 1.45% on the session, giving a market capitalisation of $47.9M. Its beta of 2.64 implies it has historically moved more than the broad market.

Immunovia AB (publ), a diagnostic company, develops blood diagnostic for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Immunovia AB is most often compared with the following Healthcare names: